BMRN (BIOMARIN PHARMACEUTICAL INC) Institutional Ownership Summary
Based on the latest SEC 13F filings, 7 institutional investors hold BMRN (BIOMARIN PHARMACEUTICAL INC) with a combined value of $1.75B across 70,804,984 shares. The largest holder is BlackRock, Inc. with a position worth $1.14B (0.02% of their portfolio). 3 funds increased their holdings. 4 funds reduced their position.
Total Institutional Value
$1.75B
Total Shares Held
70,804,984
Institutional Holders
7
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $1.14B | 0.02% | -13.2% |
| 2 | VIKING GLOBAL INVESTORS LP | $358.78M | 0.95% | -27.5% |
| 3 | CITADEL ADVISORS LLC | $99.62M | 0.01% | +137.1% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $78.74M | 0.12% | -30.0% |
| 5 | BlackRock, Inc. | $40.20M | 0.00% | +11.2% |
| 6 | Point72 Asset Management, L.P. | $26.08M | 0.03% | +0.0% |
| 7 | Bridgewater Associates, LP | $13.67M | 0.05% | -38.8% |
Track BMRN institutional moves
Get notified when hedge funds change their BMRN positions.